Immunomodulatory Agent 007 Reporting For Duty!

The new immunomodulatory agent lenalidomide has just been approved by the F.D.A. for the treatment of a specific subset of the malignant blood disease myelodysplastic syndrome.

For the details read here.

Thanks again to Kevin for letting this barmy blogger bollix up this brilliant website with his harebrained bilge! Will the good doctor ever dare to go on vacation again after this?

Sure he will, just as soon as this happens!

Prev
Next